These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 32517335)
21. Correlation Between Biofilm-Formation and the Antibiotic Resistant Phenotype in Senobar Tahaei SA; Stájer A; Barrak I; Ostorházi E; Szabó D; Gajdács M Infect Drug Resist; 2021; 14():1155-1168. PubMed ID: 33790586 [TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974 [TBL] [Abstract][Full Text] [Related]
24. Occurrence of the Colistin Resistance Gene Mikhayel M; Leclercq SO; Sarkis DK; Doublet B Microbiol Spectr; 2021 Oct; 9(2):e0002521. PubMed ID: 34494875 [TBL] [Abstract][Full Text] [Related]
25. In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern. Ponnusamy P; Natarajan V; Sevanan M Asian Pac J Trop Med; 2012 Mar; 5(3):210-3. PubMed ID: 22305786 [TBL] [Abstract][Full Text] [Related]
26. Enteroaggregative Martínez-Santos VI; Ruíz-Rosas M; Ramirez-Peralta A; Zaragoza García O; Resendiz-Reyes LA; Romero-Pineda OJ; Castro-Alarcón N PeerJ; 2021; 9():e11726. PubMed ID: 34513321 [TBL] [Abstract][Full Text] [Related]
27. Outcome of acute urinary tract infections caused by uropathogenic Pullanhi U; Khan S; Vinod V; Mohan K; Kumar A Ann Afr Med; 2019; 18(3):138-142. PubMed ID: 31417014 [TBL] [Abstract][Full Text] [Related]
28. Distribution of phylogenetic groups, adhesin genes, biofilm formation, and antimicrobial resistance of uropathogenic Tewawong N; Kowaboot S; Pimainog Y; Watanagul N; Thongmee T; Poovorawan Y PeerJ; 2020; 8():e10453. PubMed ID: 33344087 [TBL] [Abstract][Full Text] [Related]
29. Phylogenetic analysis, biofilm formation, antimicrobial resistance and relationship between these characteristics in Uropathogenic Escherichia coli. Talieh Mostaghimi ; Pournajaf A; Bijani A; Mohammadi M; Rajabnia M; Halaji M Mol Biol Rep; 2024 Feb; 51(1):327. PubMed ID: 38393446 [TBL] [Abstract][Full Text] [Related]
30. Cell death and biomass reduction in biofilms of multidrug resistant extended spectrum β-lactamase-producing uropathogenic Escherichia coli isolates by 1,8-cineole. Vazquez NM; Mariani F; Torres PS; Moreno S; Galván EM PLoS One; 2020; 15(11):e0241978. PubMed ID: 33152054 [TBL] [Abstract][Full Text] [Related]
31. High prevalence of extensively drug resistant and extended spectrum beta lactamases (ESBLs) producing uropathogenic Escherichia coli isolated from Faisalabad, Pakistan. Ehsan B; Haque A; Qasim M; Ali A; Sarwar Y World J Microbiol Biotechnol; 2023 Mar; 39(5):132. PubMed ID: 36959469 [TBL] [Abstract][Full Text] [Related]
32. Detection of biofilm among uropathogenic Karigoudar RM; Karigoudar MH; Wavare SM; Mangalgi SS J Lab Physicians; 2019; 11(1):17-22. PubMed ID: 30983797 [TBL] [Abstract][Full Text] [Related]
33. Molecular Epidemiology of Antimicrobial Resistance of Uropathogenic Neamati F; Khorshidi A; Moniri R; Hosseini Tafreshi SA Microb Drug Resist; 2020 Jan; 26(1):60-70. PubMed ID: 31526226 [TBL] [Abstract][Full Text] [Related]
34. Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India. Harwalkar A; Gupta S; Rao A; Srinivasa H J Infect Public Health; 2014; 7(5):413-9. PubMed ID: 24861644 [TBL] [Abstract][Full Text] [Related]
35. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin. Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972 [TBL] [Abstract][Full Text] [Related]
36. Fosfomycin use in multi drug resistant uropathogenic Escherichia coli. Mittal S; Sharma M; Chaudhary U Infect Disord Drug Targets; 2015; 15(3):196-201. PubMed ID: 26374327 [TBL] [Abstract][Full Text] [Related]
37. Treatment Failure in Urinary Tract Infections: A Warning Witness for Virulent Multi-Drug Resistant ESBL- Producing Naziri Z; Derakhshandeh A; Soltani Borchaloee A; Poormaleknia M; Azimzadeh N Infect Drug Resist; 2020; 13():1839-1850. PubMed ID: 32606833 [TBL] [Abstract][Full Text] [Related]
38. Phylogenetic Group B2 Expressed Significant Biofilm Formation among Drug Resistant Uropathogenic Escherichia coli. Javed S; Mirani ZA; Pirzada ZA Libyan J Med; 2021 Dec; 16(1):1845444. PubMed ID: 33170767 [TBL] [Abstract][Full Text] [Related]
39. The antibiotic susceptibility patterns of uropathogenic Escherichia coli, with special reference to the fluoroquinolones. Shariff V A AR; Shenoy M S; Yadav T; M R J Clin Diagn Res; 2013 Jun; 7(6):1027-30. PubMed ID: 23905095 [TBL] [Abstract][Full Text] [Related]
40. Relationship between antimicrobial resistance and virulence factors in uropathogenic Abed AD; Mutter TY Afr Health Sci; 2023 Sep; 23(3):486-496. PubMed ID: 38357165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]